← Leaderboards
Paul R Conlin
Brigham And Women'S Hospital
$6,611,270
Attributed
$6,611,270
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,611,270 · 8
VA$0 · 2
By mechanism
R01$4,052,095 · 2
K24$1,730,684 · 1
M01$828,491 · 5
I01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Susan S Redline$76,698,471
- Christopher Cassa$5,157,160
- Julie Lin$2,235,010
- Carl-Fredrik Westin$18,707,712
- Jonathan S Williams$3,996,120
Others in their field
Top investigators on “Characteristics”
- Lawrence Corey · Fred Hutchinson Cancer Center$259,409,773
- Jeffrey P Krischer · University Of South Florida$234,914,225
- Constance Ann Benson · University Of California, San Diego$187,977,954
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$136,053,061
- Peter B. Gilbert · Fred Hutchinson Cancer Center$118,817,242
Research focus
CharacteristicsAffectBlood PressureClinical TrialsCaringDiabetes MellitusRisk FactorsKidney DiseasesClinical ResearchPatternAfrican AmericanEquilibriumGlycosylated Hemoglobin AProviderComplexCardiovascular DiseasesBlood Glucose RegulationInterestComplications Of Diabetes MellitusEventMortalityBenefits And RisksClinical Practice GuidelineCardiovascular Disorder Risk
Grant awards (37)
Comparative and cost effectiveness of diabetes medications$0
I01 · FY2025 · VA · contact PI
Comparative and cost effectiveness of diabetes medications$0
I01 · FY2024 · VA · contact PI
Comparative and cost effectiveness of diabetes medications$0
I01 · FY2023 · VA · contact PI
Hemoglobin A1C Variability as a Risk Factor for Diabetes Complications$257,848
R01 · FY2022 · DK · contact PI
Hemoglobin A1C Variability as a Risk Factor for Diabetes Complications$252,243
R01 · FY2022 · DK · contact PI
Hemoglobin A1C Variability as a Risk Factor for Diabetes Complications$188,771
R01 · FY2022 · DK · contact PI
Comparative and cost effectiveness of diabetes medications$0
I01 · FY2022 · VA · contact PI
Hemoglobin A1C Variability as a Risk Factor for Diabetes Complications$520,406
R01 · FY2021 · DK · contact PI
Hemoglobin A1C Variability as a Risk Factor for Diabetes Complications$520,406
R01 · FY2020 · DK · contact PI
Hemoglobin A1C Variability as a Risk Factor for Diabetes Complications$590,922
R01 · FY2019 · DK · contact PI
Hemoglobin A1c Variability and Adverse Health Outcomes$0
I01 · FY2019 · VA · contact PI
Hemoglobin A1c Variability and Adverse Health Outcomes$0
I01 · FY2018 · VA · contact PI
Hemoglobin A1c Variability and Adverse Health Outcomes$0
I01 · FY2018 · VA · contact PI
Renal blood flow, vascular stiffness, and the DASH diet$197,394
K24 · FY2012 · DK · contact PI
Renal blood flow, vascular stiffness, and the DASH diet$197,394
K24 · FY2011 · DK · contact PI
Renal blood flow, vascular stiffness, and the DASH diet$197,394
K24 · FY2010 · DK · contact PI
Cardiovascular and renal hemodynamics and the DASH diet$347,562
R01 · FY2009 · HL · contact PI
Renal blood flow, vascular stiffness, and the DASH diet$197,394
K24 · FY2009 · DK · contact PI
Renal blood flow, vascular stiffness, and the DASH diet$193,458
K24 · FY2008 · DK · contact PI
CARDIOVASCULAR AND RENAL HEMODYNAMICS AND THE DASH DIET$104,960
M01 · FY2008 · RR · contact PI
CARDIOVASCULAR AND RENAL HEMODYNAMICS AND THE DASH DIET$703,461
M01 · FY2007 · RR · contact PI
Cardiovascular and renal hemodynamics and the DASH diet$456,440
R01 · FY2007 · HL · contact PI
Renal blood flow,sodium handling and the DASH diet$149,530
K24 · FY2007 · DK · contact PI
Cardiovascular and renal hemodynamics and the DASH diet$459,792
R01 · FY2006 · HL · contact PI
Renal blood flow,sodium handling and the DASH diet$149,530
K24 · FY2006 · DK · contact PI
Cardiovascular and renal hemodynamics and the DASH diet$457,705
R01 · FY2005 · HL
Renal blood flow,sodium handling and the DASH diet$149,530
K24 · FY2005 · DK
ASSESSMENT OF DIASTOLIC FUNCTION AND CENTRAL AORTIC STIFFNESS$18,755
M01 · FY2005 · RR
Renal blood flow,sodium handling and the DASH diet$149,530
K24 · FY2004 · DK
Assessment of Diastolic Function /Central Aortic Stiffne$1,315
M01 · FY2004 · RR
Renal blood flow,sodium handling and the DASH diet$149,530
K24 · FY2003 · DK
EPLERENONE &LOSARTAN IN LOW RENIN HYPERTENSION$0
M01 · FY2002 · RR
TEVETEN PLUS ENALAPRIL VERSUS PLACEBO IN AFRICAN AMERICAN PATIENTS W/HYPERTENSION$0
M01 · FY2002 · RR
EPLERENONE &LOSARTAN IN LOW RENIN HYPERTENSION$0
M01 · FY2001 · RR
TEVETEN PLUS ENALAPRIL VERSUS PLACEBO IN AFRICAN AMERICAN PATIENTS W/HYPERTENSION$0
M01 · FY2001 · RR
EPLERENONE &LOSARTAN IN LOW RENIN HYPERTENSION$0
M01 · FY2000 · RR
TEVETEN PLUS ENALAPRIL VERSUS PLACEBO IN AFRICAN AMERICAN PATIENTS W/HYPERTENSION$0
M01 · FY2000 · RR